Endo Pharmaceuticals Inc., headquartered in Malvern, PA, develops and markets high-value, quality branded pharmaceutical products for patients in need. Endo Pharmaceuticals’ specialty portfolio includes products for urology, men’s health, orthopedics and endocrinology, with product development underway in medical aesthetics. Endo Pharmaceuticals is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization. Learn more at www.endo.com or www.endopharma.com.
1400 Atwater Drive
Malvern, PA 19355
Brief summary of the
materials and/or video content:
SUPPRELIN® LA (histrelin acetate) subcutaneous implant has been used for over a decade and prescribed by pediatric endocrinologists.
To learn more about the implantation procedures, watch an experienced peer perform an in-office implant procedure at procedurevideo.com and use the following credentials (case sensitive) to log in:
Please see Important Safety Information at SupprelinLA.com
Please see full Prescribing Information for SUPPRELIN® LA.
Have questions? Please contact:
For all other enquiries please contact us at https://www.endo.com/endopharma/contact-us
Enter the MAP Spotlight Raffle